Yue Zhao

Prof. Yue Zhao

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Molecular Cell
Verified
Journal Article
Closed access
YZYue Zhao
Yue Zhao
GLGuillaume Lang
Guillaume Lang
SISaya Ito
Saya Ito
JBJacques Bonnet
Jacques Bonnet
EMEric Metzger
Eric Metzger
DDDidier Devys
Didier Devys

21 August 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CLChi Lv
Chi Lv
SWShengli Wang
Shengli Wang
LLLin Lin
Lin Lin
CWChunyu Wang
Chunyu Wang
KZKai Zeng
Kai Zeng
YZYue Zhao
Yue Zhao
Hepatocellular carcinoma (HCC) is the most common visceral neoplasms with its heterogeneity and high rate of recurrence. HCC is characterized to be delayed diagnosis and the development of resistant disease. However, the molecular mechanism for HCC pathogenesis and progression remains largely unknown. Here, we demonstrated that ubiquitin-specific protease14 (USP14) is highly expressed in HCC samples, and the higher expression of USP14 is positively correlated with poor prognosis. Interestingly, USP14 is involved in the maintenance of HIF1-α stability to activate HIF1-α-induced transactivation via its deubiquitinase activity. USP14 depletion or its specific inhibitor IU1 treatment decreased cell proliferation, invasion, migration, and Vascular Mimicry (VM) formation even under hypoxia conditions in HCC cell lines. Moreover, we provided the evidence to show that knockdown of USP14 or USP14 inhibitor (IU1) treatment inhibited tumor growth in tumor-bearing nude mice. Our findings suggest that USP14 maintains HIF1-α stability through its deubiquitination activity, providing a potential biomarker for the early diagnosis and therapy of HCC.

30 April 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CWChunyu Wang
Chunyu Wang
HSHongmiao Sun
Hongmiao Sun
RZRenlong Zou
Renlong Zou
TZTingting Zhou
Tingting Zhou
SWShengli Wang
Shengli Wang
YZYue Zhao
Yue Zhao
Mediator of DNA damage checkpoint protein 1 (MDC1) is essential for DNA damage response. However, the role of MDC1 in modulating gene transcription independently of DNA damage and the underlying mechanisms have not been fully defined. Androgen receptor (AR) is the central signaling pathway in prostate cancer (PCa) and its target genes are involved in both promotion and suppression of PCa. Here, we functionally identified MDC1 as a co-activator of AR. We demonstrate that MDC1 facilitates the association between AR and histone acetyltransferase GCN5, thereby increasing histone H3 acetylation level on cis-regulatory elements of AR target genes. MDC1 knockdown promotes PCa cells growth and migration. Moreover, depletion of MDC1 results in decreased expression of a subset of the endogenous androgen-induced target genes, including cell cycle negative regulator p21 and PCa metastasis inhibitor Vinculin, in AR positive PCa cell lines. Finally, the expression of MDC1 and p21 correlates negatively with aggressive phenotype of clinical PCa. These studies suggest that MDC1 as an epigenetic modifier regulates AR transcriptional activity and MDC1 may function as a tumor suppressor of PCa, and provide new insight into co-factor-AR-signaling pathway mechanism and a better understanding of the function of MDC1 on PCa.

1 August 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YZYue Zhao
Yue Zhao
KGKiminobu Goto
Kiminobu Goto
MSMasayuki Saitoh
Masayuki Saitoh
TYToshihiko Yanase
Toshihiko Yanase
MNMasatoshi Nomura
Masatoshi Nomura
HNHajime Nawata
Hajime Nawata
In the androgen receptor (AR), most of its transactivation activity is mediated via the activation function-1 (AF-1). By employing yeast two-hybrid assay, we isolated a cDNA sequence encoding a protein binding to AR-AF-1. This protein, named ANT-1 (AR N-terminal domain transactivating protein-1), enhanced the ligand-independent autonomous AF-1 transactivation function of AR or glucocorticoid receptor but did not enhance that of estrogen receptor α. In contrast, the ANT-1 did not enhance any ligand-dependent AF-2 activities. Furthermore, the ligand-independent interaction between AR-AF-1 and ANT-1 was confirmedin vivo and in vitro. The ANT-1 sequence was identical to that of a protein that binds to U5 small nuclear ribonucleoprotein particle, a human homologue of yeast splicing factor Prp6p, involved in spliceosome. ANT-1 was compartmentalized into 20–40 coarse splicing factor compartment speckles against the background of the diffuse reticular distribution. AR colocalized with ANT-1 only in the diffusely distributed area, whereas the ANT-1 speckles were spatially distinct from but surrounded by the AR compartments. The active gene transcription has been shown to couple simultaneously with pre-mRNA processing at the periphery of the splicing factor compartment. The molecular interaction between two spatially distinct subnuclear compartments mediated by ANT-1 may therefore recruit AR into the transcription-splicing-coupling machinery.

3 June 2020 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
SWShengli Wang
Shengli Wang
XZXinping Zhong
Xinping Zhong
CWChunyu Wang
Chunyu Wang
HLHao Luo
Hao Luo
LLLin Lin
Lin Lin
YZYue Zhao
Yue Zhao

1 January 2015 in International Journal of Biological Sciences
Verified
Journal Article
Open access
RZRenlong Zou
Renlong Zou
XZXinping Zhong
Xinping Zhong
CWChunyu Wang
Chunyu Wang
HSHongmiao Sun
Hongmiao Sun
SWShengli Wang
Shengli Wang
YZYue Zhao
Yue Zhao
Estrogen receptor α (ERα) is a key transcriptional factor in the proliferation and differentiation in mammary epithelia and has been determined to be an important predictor of breast cancer prognosis and therapeutic target. Meanwhile, diverse transcriptional co-regulators of ERα play crucial and complicated roles in breast cancer progression. Mediator of DNA damage checkpoint 1 (MDC1) has been identified as a critical upstream mediator in the cellular response to DNA damage, however, some non-DNA damage responsive functions of MDC1 haven't been fully defined. In this study, we have identified MDC1 as a co-activator of ERα in breast cancer cells and demonstrated that MDC1 associates with ERα. MDC1 was also recruited to estrogen response element (ERE) of ERα target gene. Knockdown of MDC1 reduced the transcription of the endogenous ERα target genes, including p21. MDC1 depletion led to the promotion of breast cancer progression, and the expression of MDC1 is lower in breast cancer. Taken together, these results suggested that MDC1 was involved in the enhancement of ERα-mediated transactivation in breast cancer cells. This positive regulation by MDC1 might contribute to the suppression of breast cancer progression by acting as a barrier of positive to negative ERα function transformation.